Cluster of differentiation 3 (CD3) complex (CD3)

The *Cluster of Differentiation 3* (**CD3**) is a multimeric protein complex expressed exclusively on mature *T lymphocytes*. It serves as an essential co-receptor that associates noncovalently with the *T-cell receptor* (*TCR*) αβ or γδ heterodimers forming the complete *TCR–CD3* complex critical for antigen recognition and subsequent intracellular signal transduction[1][2][5]. The canonical human CD3 complex consists primarily of four distinct polypeptide chains arranged into three dimers: 1. A heterodimer composed of gamma (γ) and epsilon (ε) chains, 2. A heterodimer composed of delta (δ) and epsilon (ε) chains, and 3. A homodimer composed mainly by two zeta (ζ) chains. Each chain belongs to the immunoglobulin superfamily with extracellular Ig-like domains facilitating assembly with each other and association with variable αβ/γδ subunits[1][5]. The transmembrane regions contain charged residues that mediate stable interactions within this multi-subunit structure[4]. Intracellularly, all these subunits contain conserved motifs called *immunoreceptor tyrosine-based activation motifs* (**ITAMs**). The γ, δ, ε subunits each have one ITAM motif while ζ contains three ITAMs per chain resulting in ten total ITAMs per assembled receptor[1][5]. These motifs are phosphorylated upon antigen engagement through Src family kinases like Lck/Fyn initiating downstream signaling cascades crucial for full activation, proliferation, differentiation, or apoptosis decisions within responding T cells[5]. Structurally resolved studies using CryoEM have shown how these components assemble around the variable region-containing αβ-TCR ectodomains forming a stable yet dynamic platform enabling precise control over immune responses triggered by peptide-MHC complexes presented by antigen-presenting cells[1][4]. Therapeutically targeting this molecule has been exploited using monoclonal antibodies such as muromonab-CD3, which binds specifically to one component—usually ε-chain—to modulate pathological immune responses including transplant rejection prevention but carries risks like cytokine release syndrome due to massive polyclonal stimulation[5].

Other names

T-cell antigen receptor complex-associated proteinTCR-CD3 complexCD3εγ heterodimerCD3εδ heterodimerCD3ζζ homodimer

Drugs targeting CD3 typically bind extracellular domains on ε or other chains to modulate or block TCR signaling. Antibody binding induces conformational changes leading to altered ITAM phosphorylation states. Can cause depletion or functional modulation of activated T cells by triggering activation-induced cell death or anergy.